Your browser doesn't support javascript.
loading
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial).
Michl, M; Stintzing, S; Fischer von Weikersthal, L; Decker, T; Kiani, A; Vehling-Kaiser, U; Al-Batran, S-E; Heintges, T; Lerchenmueller, C; Kahl, C; Seipelt, G; Kullmann, F; Stauch, M; Scheithauer, W; Hielscher, J; Scholz, M; Mueller, S; Lerch, M M; Modest, D P; Kirchner, T; Jung, A; Heinemann, V.
Affiliation
  • Michl M; Department of Hematology and Medical Oncology, Klinikum Grosshadern and Comprehensive Cancer Center Munich, Ludwig-Maximilians-University Munich, Munich marlies.michl@med.uni-muenchen.de.
  • Stintzing S; Department of Hematology and Medical Oncology, Klinikum Grosshadern and Comprehensive Cancer Center Munich, Ludwig-Maximilians-University Munich, Munich German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg.
  • Fischer von Weikersthal L; Practice for Hematology and Medical Oncology, Gesundheitszentrum St Marien, Amberg.
  • Decker T; Practice for Hematology and Medical Oncology, Onkonet-Onkologie Ravensburg, Ravensburg.
  • Kiani A; Department of Hematology and Medical Oncology, Klinik Herzoghöhe, Bayreuth.
  • Vehling-Kaiser U; Practice for Hematology and Medical Oncology, Landshut.
  • Al-Batran SE; Department of Hematology and Medical Oncology, Krankenhaus Nordwest, University Cancer Center Frankfurt, Frankfurt.
  • Heintges T; Department of Gastroenterology and Oncology, Medical Department II, Lukaskrankenhaus, Städtisches Klinikum Neuss, Neuss.
  • Lerchenmueller C; Practice for Hematology and Medical Oncology, Muenster.
  • Kahl C; Department of Hematology and Medical Oncology, Klinikum Magdeburg, Magdeburg.
  • Seipelt G; Practice for Hematology and Medical Oncology, Bad Soden.
  • Kullmann F; Department of Gastroenterology, Hematology and Medical Oncology, Klinikum Weiden, Weiden.
  • Stauch M; Practice for Hematology and Medical Oncology, Kronach, Germany.
  • Scheithauer W; Department of Hematology and Medical Oncology, Medical University of Vienna, Vienna, Austria.
  • Hielscher J; Department of Surgery, Klinikum Chemnitz, Chemnitz.
  • Scholz M; Department of Medicine, Klinikum Stuttgart, Stuttgart.
  • Mueller S; Practice for Hematology and Medical Oncology, Ansbach.
  • Lerch MM; Department of Medicine A, University Medicine Greifswald, Greifswald.
  • Modest DP; Department of Hematology and Medical Oncology, Klinikum Grosshadern and Comprehensive Cancer Center Munich, Ludwig-Maximilians-University Munich, Munich German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg.
  • Kirchner T; Department of Pathology, Klinikum Grosshadern, Ludwig-Maximilians-University Munich, Munich, Germany German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg.
  • Jung A; Department of Pathology, Klinikum Grosshadern, Ludwig-Maximilians-University Munich, Munich, Germany German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg.
  • Heinemann V; Department of Hematology and Medical Oncology, Klinikum Grosshadern and Comprehensive Cancer Center Munich, Ludwig-Maximilians-University Munich, Munich German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg.
Ann Oncol ; 27(8): 1565-72, 2016 08.
Article in En | MEDLINE | ID: mdl-27234640
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Camptothecin / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carcinoembryonic Antigen / Proto-Oncogene Proteins p21(ras) / Bevacizumab / Cetuximab Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Camptothecin / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carcinoembryonic Antigen / Proto-Oncogene Proteins p21(ras) / Bevacizumab / Cetuximab Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2016 Type: Article